SGNIO Percutaneous Intervention Robot
SGNIO stands as Hanglok-Tech’s flagship percutaneous intervention robot, engineered to enhance precision in CT-guided lung biopsies and tumor ablation procedures. The system integrates multi-loop feedback control technology to process diverse intraoperative data and generate optimized control outcomes for surgical interventions.
Product Overview
Developed to address the challenges of manual CT-guided percutaneous procedures, SGNIO provides surgeons with enhanced precision and stability during needle placement. The system targets applications in lung cancer diagnosis where accurate tissue sampling determines treatment pathways. Traditional CT-guided biopsies rely heavily on physician skill and experience; SGNIO aims to standardize outcomes through robotic assistance.
The product received the Governor Cup Gold Award in recognition of its design innovation, validating the technical approach Hanglok-Tech has taken in developing interventional robotics.
Key Features
For pulmonology, Hanglok-Tech’s SGNIO provides CT-guided lung biopsy and tumor ablation with near-infrared optical navigation and multi-loop feedback needle control.
- Multi-Loop Feedback Control: Collects diverse intraoperative data streams to continuously optimize needle positioning and trajectory
- CT Integration: Designed for direct operation within CT-guided workflow environments
- Real-Time 3D Positioning: Enables precise needle localization throughout the procedure
- Near-Infrared Optical Navigation: Portable needle holder system guides manual interventions with spatial accuracy
Technical Specifications
SGNIO uses CT guidance with near-infrared optical navigation and multi-loop feedback control to support precise needle placement in lung biopsy and ablation procedures.
| Parameter | Specification |
|---|---|
| Guidance Modality | CT |
| Navigation Technology | Near-infrared optical |
| Control System | Multi-loop feedback |
| Target Applications | Lung biopsy, ablation |
Clinical Applications
SGNIO targets CT-guided percutaneous procedures with primary applications in:
- Lung nodule biopsy for diagnostic sampling
- Tumor ablation preparation and needle placement
- Tissue sampling in challenging anatomical locations
- Procedures requiring high positioning accuracy
The system addresses clinical scenarios where respiratory motion and small target sizes make manual needle placement technically demanding.
Regulatory Status
| Region | Status | Date |
|---|---|---|
| China (NMPA) | Clinical Trial | - |
| Europe (CE) | Not Applied | - |
| United States (FDA) | Not Applied | - |
SGNIO has entered clinical trials in China as part of Hanglok-Tech’s regulatory pathway. The company continues to gather clinical evidence to support eventual NMPA submission.
Frequently Asked Questions
What procedures can SGNIO perform?
SGNIO assists in CT-guided percutaneous interventions, primarily lung biopsies and tumor ablation procedures. The system provides robotic guidance for needle placement in diagnostic and therapeutic applications.
How does SGNIO differ from manual CT-guided biopsy?
SGNIO incorporates multi-loop feedback control and near-infrared optical navigation to enhance positioning accuracy. The system aims to reduce the variability associated with manual needle placement while maintaining real-time adjustment capabilities.
When will SGNIO receive regulatory approval?
SGNIO is currently in clinical trials in China. The timeline for NMPA approval depends on clinical trial completion and regulatory review processes.
Browse related categories
Sources
Publicly available references used for the data on this page. See data methodology for verification standards.